WASHINGTON, DC (November 2, 2015) – LUNGevity Foundation today launched a new and innovative resource that enables patients to more easily find clinical trials that could extend their lives. Many patients have difficulty with the process of reviewing clinical trials online and identifying opportunities for which they qualify. To help, LUNGevity has joined forces with Lilly Oncology to develop an online tool that streamlines the process and eases navigation of clinical trial searches. Using filters such as geographic location, gender, stage of the disease and histology, the tool displays clinical trials relevant to the patient in easy-to-understand language and graphics.
“LUNGevity’s new Clinical Trial Finder allows people to be proactive in their diagnoses, providing access to critical information that can change outcomes for patients and allow those patients to participate in the research process,” noted Charlie Rudin, LUNGevity Scientific Advisory Board Chair and Professor and Chief of Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center. “Clinical trials often offer patients access to the most advanced treatments that could help extend their lives."
“Scientists are conducting more lung cancer clinical trials than ever before, which creates challenges for patients who must sift through a high volume of information that is often difficult to understand in order to find the right opportunities for them,” added President of LUNGevity Andrea Ferris. “LUNGevity’s top priorities are to support patients and advance life-changing research. One of the best ways for us to do that is to direct patients to the trials for which they qualify.”
The Clinical Trial Finder was developed by Composite Apps in partnership with Lilly Oncology.
To explore the new Clinical Trial Finder, visit www.LUNGevity.org/clinicaltrialfinder.
For more information on LUNGevity, please visit www.LUNGevity.org.
About Lung Cancer
- 1 in 15 Americans will be diagnosed with lung cancer in their lifetime
- More than 221,000 people in the U.S. will be diagnosed with lung cancer this year
- About 60%-65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
- Lung cancer takes more lives than the next three leading cancers (colorectal, breast, and prostate) combined
- Only 17% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it’s caught before it spreads, the chance for 5-year survival improves dramatically